Skip to main content
Clinical Trials/NCT06132451
NCT06132451
Not yet recruiting
Not Applicable

In-Hospital Detection of Elevated Blood Pressure (INDEBP): Prevalence of New or Uncontrolled Hypertension and Safety of Postponement of Antihypertensive Treatment Adaption in Medical In-patients

Annina Vischer1 site in 1 country800 target enrollmentNovember 7, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hypertension
Sponsor
Annina Vischer
Enrollment
800
Locations
1
Primary Endpoint
Prevalence of persisting new or uncontrolled arterial hypertension
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

The goal of this clinical trial is to analyse the prevalence of new or uncontrolled arterial hypertension (AHT) after hospital discharge of medical in-patients with elevated blood pressure (BP) values during hospitalisation.

The main questions it aims to answer are:

  • Do elevated BP values during hospitalisation correspond to new or uncontrolled AHT after hospital discharge?
  • Is it safe to postpone adaption of antihypertensive treatment until after proper evaluation of AHT after hospital discharge?

Participants will either be treated according to their physicians' decision or antihypertensive treatment adaptions will be postponed until after hospital discharge.

Registry
clinicaltrials.gov
Start Date
November 7, 2023
End Date
December 31, 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Annina Vischer
Responsible Party
Sponsor Investigator
Principal Investigator

Annina Vischer

Principle Investigator

University Hospital, Basel, Switzerland

Eligibility Criteria

Inclusion Criteria

  • Patient hospitalized on the internal medicine ward for non-cardiovascular causes, i.e. patients hospitalized for conditions, which are not acutely worsened by uncontrolled AHT
  • Asymptomatic elevated BP values (defined as 140-180 mmHg systolic and/or 90-110 mmHg diastolic) on at least 2 occasions
  • Ability to understand study procedures and to provide written informed consent

Exclusion Criteria

  • Hospitalization for any conditions which can be worsened by uncontrolled AHT:
  • Cerebrovascular events
  • Acute coronary syndrome
  • Acute or decompensated heart failure
  • Any condition preventing ABPM
  • Pregnant or lactating women
  • Failure to provide informed consent

Outcomes

Primary Outcomes

Prevalence of persisting new or uncontrolled arterial hypertension

Time Frame: 4 weeks after hospital discharge

Elevated blood pressure values in ambulatory blood pressure monitoring

Prevalence of a combined hypertensive complication endpoint

Time Frame: Until 4 weeks after hospital discharge

Consisting of intracerebral bleeding, ischemic stroke, myocardial infarction, cardiovascular death or cardiovascular re-hospitalization

Prevalence of a combined hypotensive complication endpoint

Time Frame: Until 4 weeks after hospital discharge

Consisting of falls, acute kidney injury, electrolyte disturbances, re-hospitalizations due to hypotension, or BP values on ABPM below the lower treatment limit

Secondary Outcomes

  • Prevalence of re-hospitalization for any cause(Until 4 weeks after hospital discharge)
  • Clinic blood pressure measurement in mmHg(At baseline)
  • Research blood pressure measurement in mmHg(At baseline)
  • Prevalence of previously unknown arterial hypertension(At baseline)
  • Prevalence of female gender(At baseline)

Study Sites (1)

Loading locations...

Similar Trials